HAPPY NEW YEAR: BIG PHARMA HIKES PRICES ON MORE THAN 580 RX DRUGS TO START 2021
Jan 4, 2021
Drug Companies Double Down In Second Major Round Of Pandemic Price Hikes As… Read More
© 2024 CSRXP- All Rights Reserved
Press & Statements
CSRXP STATEMENT ON SELECTION OF XAVIER BECERRA FOR THE U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES
Dec 7, 2020
Campaign Looks Forward to Working with Becerra to Lower Drug Prices… Read More
CSRXP: BIG PHARMA MUST BE HELD ACCOUNTABLE FOR ESCALATING ASSAULT ON CRITICAL 340B PROGRAM
Dec 3, 2020
Novo Nordisk Becomes Latest Drug Company to Dodge Requirement to Provide… Read More
CSRxP: MISGUIDED REBATE RULE A BIG PHARMA BAILOUT PAID FOR BY AMERICAN SENIORS & TAXPAYERS
Nov 20, 2020
Rebate Rule Will Increase Premiums for Medicare Part D Beneficiaries… Read More
CSRXP: COVID-19 TREATMENTS AND VACCINES MUST BE ACCESSIBLE AND AFFORDABLE FOR ALL AMERICANS
Nov 9, 2020
Pfizer Releases Positive Preliminary Data on Vaccine, Must Commit to… Read More
CSRXP: GILEAD’S PRICE-GOUGING AMERICAN PUBLIC ON COVID-19 TREATMENT TAXPAYERS PAID TO DEVELOP
Oct 30, 2020
Big Pharma Company Reaping Profit Margin Higher Than 90 Percent on Remdesivir… Read More
CSRXP: PRESIDENTIAL CAMPAIGNS MUST BACK BIPARTISAN, MARKET-BASED SOLUTIONS TO HOLD BIG PHARMA ACCOUNTABLE
Oct 13, 2020
Surrogates for the 2020 Candidates Should Demonstrate Commitment To Lowering… Read More
CSRXP: ASTRAZENECA LEADS BIG PHARMA IN BRAZEN ASSAULT ON CRITICAL 340B PROGRAM, MUST BE HELD ACCOUNTABLE
Oct 1, 2020
Brand Name Drug Company Shirks Requirement to Provide Affordable Medications… Read More
CSRXP COMMENDS LAWMAKERS FOR REFOCUSING CRITICAL ATTENTION ON BIG PHARMA’S EGREGIOUS PRICE HIKES AND PRACTICES
Sep 30, 2020
House Committee on Oversight and Reform to Question Big Pharma Executives… Read More
NEW STUDY: BIG PHARMA’S BIOLOGIC PATENT ABUSE WILL COST AMERICAN PATIENTS AN ADDITIONAL $25 BILLION WITHOUT REFORM
Sep 22, 2020
Report Finds Market-Based Solutions to Boost Biosimilar Competition and Hold… Read More
CSRXP: PRESIDENT SHOULD FOCUS ON HOLDING BIG PHARMA ACCOUNTABLE TO LOWER RX PRICES, ABANDON REBATE RULE
Sep 13, 2020
Tweet Misstates Impact of Misguided Rebate Rule That Would Do Nothing to Lower… Read More
CSRxP Commends Congressional Probe Of Big Pharma Giant’s Anti-Competitive Tactics and Egregious Pricing Practices
Sep 1, 2020
U.S. House Oversight Committee Subpoena of AbbVie Related to Pricing of… Read More